Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Net Cash Flow (2021 - 2025)

Cingulate's (CING) quarterly Net Cash Flow came in at $4.8 million in Q4 2025, up 122.68% on a YoY basis from $2.2 million in Q4 2024, and up 273.82% quarter-over-quarter from -$2.8 million in Q3 2025.

Analysis

Cingulate (CING) Net Cash Flow (2021 - 2025) Analysis & Trends

Cingulate (CING) has reported Net Cash Flow for 5 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 122.68% year-over-year to $4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 million (down 110.3% YoY), and the FY2025 full-year result was -$1.3 million, down 110.35% from the prior year.
  • Net Cash Flow improved to $4.8 million in Q4 2025 per CING's latest filing, from -$2.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $14.6 million in Q4 2021 and bottomed at -$4.4 million in Q4 2022.
  • Historically, Net Cash Flow has averaged $488081.8 across 5 years, with a median of -$501143.5 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Net Cash Flow slumped 1971.64% in 2022, then soared 490.24% in 2024.
  • Over 5 years, Net Cash Flow stood at $14.6 million in 2021, then plunged by 130.45% to -$4.4 million in 2022, then surged by 56.44% to -$1.9 million in 2023, then jumped by 212.27% to $2.2 million in 2024, then jumped by 122.68% to $4.8 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $4.8 million, -$2.8 million, and -$612858.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -1.27 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -2.82 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 757.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -722.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -851.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 918.27 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 374.50 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 407.41 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.83 Mn
Sep 30, 2025 -2.78 Mn
Jun 30, 2025 -612,858.00
Mar 31, 2025 -2.69 Mn
Dec 31, 2024 2.17 Mn
Sep 30, 2024 9.66 Mn
Jun 30, 2024 -732,903.00
Mar 31, 2024 1.06 Mn
Dec 31, 2023 -1.93 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 -1.39 Mn
Mar 31, 2023 -3.62 Mn
Dec 31, 2022 -4.44 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 -4.42 Mn
Mar 31, 2022 -3.88 Mn
Dec 31, 2021 14.58 Mn
Sep 30, 2021 871,100.00
Jun 30, 2021 236,072.00
Mar 31, 2021 -389,429.00
API Access

Cingulate Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CING&period=max&api_key=YOUR_API_KEY